JAMAevidence Users' Guides to the Medical Literature

Advertise on podcast: JAMAevidence Users' Guides to the Medical Literature

Rating
4.7
from
14 reviews
This podcast has
54 episodes
Language
Publisher
Explicit
No
Date created
2018/03/12
Average duration
20 min.
Release period
84 days

Description

JAMA editors and authors explain the methods underlying clinical research to help students, trainees, and health professionals use the published medical literature to make evidence-based decisions for patients. JAMAevidence is an evidence-based medicine (EBM) resource created and maintained by the JAMA Network to promote the use of EBM to improve patient care.

Social media

Check JAMAevidence Users' Guides to the Medical Literature social media presence


Podcast episodes

Check latest episodes from JAMAevidence Users' Guides to the Medical Literature podcast


Assessing the Strength of Recommendations: The GRADE Approach With Dr Vandvik
2023/10/05
Gordon H. Guyatt, MD, MSc, discusses Assessing the Strength of Recommendations: The GRADE Approach with Per Olav Vandvik, MD, PhD. Related Content: How to Interpret and Use a Clinical Practice Guideline or Recommendation
more
Understanding and Applying the Results of a Systematic Review With Dr Murad
2023/09/07
Host Gordon Guyatt, MD, MSc, discusses Understanding and Applying the Results of a Systematic Review with M. Hassan Murad, MD, MPH. Related Content: How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care Acute Treatments for Episodic Migraine in Adults
more
Fixed-Effects and Random-Effects Models With Dr Murad
2023/07/06
Gordon H. Guyatt, MD, MSc, discusses Fixed-Effects and Random-Effects Models with M. Hassan Murad, MD. Related Content: Random-Effects Meta-analysis
Adjusted Analyses in Studies Addressing Therapy and Harm With Dr Agoritsas
2023/02/02
Gordon H. Guyatt, MD, MSc, discusses Adjusted Analyses in Studies Addressing Therapy and Harm with Thomas Agoritsas, MD, PhD. Related Content: Adjusted Analyses in Studies Addressing Therapy and Harm
more
Spectrum Bias With Dr Reem A. Mustafa
2022/12/01
Gordon Guyatt, MD, MSc, discusses Spectrum Bias with Reem A. Mustafa. MD, MPH, PhD.
Discrimination and Calibration of Clinical Prediction Models With Dr Alba
2022/10/06
Gordon Guyatt, MD, MSc, discusses Discrimination and Calibration of Clinical Prediction Models with Ana Carolina Alba, MD, PhD. Related Content: Discrimination and Calibration of Clinical Prediction Models With Dr Alba Read Transcript
more
How to Interpret and Use a Clinical Practice Guideline or Recommendation With Dr Gordon Guyatt and Dr Brignardello-Petersen
2022/07/07
Host Robert M. Golub, MD, discusses How to Interpret and Use a Clinical Practice Guideline or Recommendation with Gordon H. Guyatt, MD, MSc, and Romina Brignardello-Petersen, DDS, MSc, PhD.
more
Measuring Agreement Beyond Chance With Dr Thomas McGinn
2022/06/02
Gordon Guyatt, MD, discusses Measuring Agreement Beyond Chance with Thomas McGinn, MD, MPH. Related Content: Does This Patient Have Infectious Mononucleosis? The Rational Clinical Examination Systematic Review
more
Correlation and Regression With Dr Jaeschke
2022/03/03
Gordon H. Guyatt, MD, MSc, discusses Correlation and Regression with Roman Jaeschke, MD, MSc. 
Economic Analysis With Dr Paul Moayyedi
2021/11/04
Gordon Guyatt, MD, discusses economic analysis with Paul Moayyedi, PhD
Misleading Presentations of Clinical Trial Results with Dr Victor Montori
2021/07/01
Gordon Guyatt, MD, discusses Misleading Presentations of Clinical Trial Results with Victor Montori, MD Related Content: Misleading Presentations of Clinical Trial Results with Dr Victor Montori When Can Intermediate Outcomes Be Used in Clinical Trials? When Guidelines Recommend Shared Decision-making
more
Surrogate Outcomes from the Users’ Guides to the Medical Literature
2021/04/01
Anne M. Holbrook, MD and Gordon Guyatt, MD, discuss Surrogate Outcomes from the JAMA Users’ Guides to the Medical Literature Related Content: When Can Intermediate Outcomes Be Used as Surrogate Outcomes? FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019 What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?
more

Podcast reviews

Read JAMAevidence Users' Guides to the Medical Literature podcast reviews


4.7 out of 5
14 reviews
Anonymous132456789 2020/01/03
Very Good
I am a third year medical student, and this book is exactly what I was looking for back in first year. I have listened to some of these podcast 3-4 ti...
more
check all reviews on aple podcasts

Podcast sponsorship advertising

Start advertising on JAMAevidence Users' Guides to the Medical Literature & sponsor relevant audience podcasts


What do you want to promote?

Ad Format

Campaign Budget

Business Details